Inventor
MATTHEW FRANKLIN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%
C12YEnzymes14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
G06FElectric digital data processing3%
PatentTitleYear
12,254,347Data pipeline202511,505,594Anti-VEGF protein compositions and methods for producing the same202211,440,950Anti-VEGF protein compositions and methods for producing the same202211,407,813Anti-VEGF protein compositions and methods for producing the same202211,180,540Anti-VEGF protein compositions and methods for producing the same2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to REGENERON PHARMA (5)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 5 | 2021–2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2025 |